These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738 [TBL] [Abstract][Full Text] [Related]
84. [Treatment of familial amyloid polyneuropathy]. Adams D; Samuel D; Slama M Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949 [TBL] [Abstract][Full Text] [Related]
86. Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy. Abdelfatah MM; Hayman SR; Gertz MA Amyloid; 2014 Jun; 21(2):136-7. PubMed ID: 24517476 [No Abstract] [Full Text] [Related]
87. Arrhythmia--a pitfall in tests of cardiac autonomic function after liver transplantation for familial amyloidotic polyneuropathy: a long-term follow-up of Swedish patients. Hörnsten R; Suhr OB; Olofsson BO; Wiklund U Amyloid; 2012 Jun; 19(2):81-6. PubMed ID: 22587458 [TBL] [Abstract][Full Text] [Related]
88. The transthyretin amyloidoses: advances in therapy. Dubrey S; Ackermann E; Gillmore J Postgrad Med J; 2015 Aug; 91(1078):439-48. PubMed ID: 26048914 [TBL] [Abstract][Full Text] [Related]
89. Temporary auxiliary liver transplantation from living donor to an adult recipient with familial amyloid polyneuropathy. Ikegami T; Nishizaki T; Shimada M Transplantation; 2002 Nov; 74(9):1356. PubMed ID: 12451280 [No Abstract] [Full Text] [Related]
90. Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis. Donnellan E; Wazni OM; Hanna M; Kanj M; Saliba WI; Jaber WA J Am Heart Assoc; 2020 Jul; 9(14):e017335. PubMed ID: 32633203 [No Abstract] [Full Text] [Related]
91. [Developments in the treatment of hereditary amyloid neuropathies]. Adams D Rev Neurol (Paris); 2004 Dec; 160(12):1234-8. PubMed ID: 15602375 [No Abstract] [Full Text] [Related]
93. End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases. Rocha A; Beirão I; Pessegueiro H; Almeida R; Lobato L Amyloid; 2017 Mar; 24(sup1):85-86. PubMed ID: 28434351 [No Abstract] [Full Text] [Related]
94. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation. Lobato L; Ventura A; Beirão I; Miranda HP; Seca R; Henriques AC; Teixeira M; Sarmento AM; Pereira MC Transplant Proc; 2003 May; 35(3):1116-20. PubMed ID: 12947881 [No Abstract] [Full Text] [Related]
95. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report. Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280 [No Abstract] [Full Text] [Related]
96. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation. Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090 [TBL] [Abstract][Full Text] [Related]